Business Practice

Sitting Down With… Stanley Crooke, Chairman of the Board & Chief Executive Officer at Ionis Pharmaceuticals.

Rather than fearing the unknown, the concept of optionality can help you better manage it.

Oscars of science, drug shortage reporting requirements, and a new gene therapy... What’s new for pharma in business?

Sitting Down With... Vivek Sharma, CEO of Piramal Pharma Solutions.

The business of making biopharmaceuticals is expensive – so the more data you have to back up decisions, the better.

Can blockchain transform how we use, share, interact with and benefit from it.

Eva discovers that Gene's project management skills leave a lot to be desired...

A new gene therapy, a procurement process gone wrong, and backing away from a biosimilar…

Collaboration seeks to use artificial intelligence to predict how patients will respond to immunotherapy.

Recognizing and celebrating the efforts of both male and female scientists.